Voyager Therapeutics Announces License Option Agreement

Voyager receives $54 million upfront with potential option exercise fees and milestone payments of up to $1.7 billion plus product sales-based royalties ...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Allen Nunnally ,Exchange Commission ,Pfizer ,Voyager Therapeutics Inc ,Nasdaq ,Novartis ,Tropism Redirection ,Cell Type Specific Expression ,Glenn Pierce ,Voyager Therapeutics ,Private Securities Litigation Reform Act ,Annual Report ,Nasdaq Vygr ,Nc ,